Improve gait through smartphone training
- Trial ID
- NCT07380737
- Official Title
- Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
- Goal
- Improve gait through smartphone training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson's Disease
- Interventions
- Walking Tall App
Plain-Language Summary
The aim is to see if a smartphone app can help people with Parkinson's practice gait and balance exercises at home to improve walking quality and confidence between clinic visits. The Walking Tall App guides tailored walking exercises, uses your phone to cue steps and timing, tracks walking patterns, and gives feedback so you can work on step length, rhythm, and stability alongside your usual rehab. They are enrolling adults 40 to 85 with idiopathic Parkinson's at Hoehn and Yahr stage II or III while ON medication, who can walk independently for at least five minutes, have had stable medications for a month, are enrolled in the Ezra LeMarpe rehab program, and can use a smartphone. People with major cognitive problems, other conditions that affect gait, serious cardiovascular contraindications, or inability to use a smartphone are excluded.
Locations
- Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, Israel
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Walking Tall App. The aim is to see if a smartphone app can help people with Parkinson's practice gait and balance exercises at home to improve walking quality and confidence between clinic visits. The Walking Tall App guides tailored walking exercises, uses your phone to cue steps and timing, tracks walking patterns, and gives feedback so you can work on step length, rhythm, and stability alongside your usual rehab. They are enrolling adults 40 to 85 with idiopathic Parkinson's at Hoehn and Yahr stage II or III while ON medication, who can walk independently for at least five minutes, have had stable medications for a month, are enrolled in the Ezra LeMarpe rehab program, and can use a smartphone. People with major cognitive problems, other conditions that affect gait, serious cardiovascular contraindications, or inability to use a smartphone are excluded.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 8 months.